Japan Lifeline Co., Ltd. Stock

Equities

7575

JP3754500001

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-04-26 EDT 5-day change 1st Jan Change
1,161 JPY +1.57% Intraday chart for Japan Lifeline Co., Ltd. +1.75% -8.08%

Financials

Sales 2024 * 51.1B 323M 441M Sales 2025 * 52.64B 332M 454M Capitalization 86.99B 549M 751M
Net income 2024 * 8.07B 50.96M 69.65M Net income 2025 * 8B 50.49M 69.01M EV / Sales 2024 * 1.42 x
Net cash position 2024 * 14.56B 91.94M 126M Net cash position 2025 * 18.24B 115M 157M EV / Sales 2025 * 1.31 x
P/E ratio 2024 *
11 x
P/E ratio 2025 *
11 x
Employees 1,166
Yield 2024 *
3.38%
Yield 2025 *
3.47%
Free-Float 59.18%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.57%
1 week+1.75%
Current month-4.68%
1 month-7.27%
3 months-11.44%
6 months+5.55%
Current year-8.08%
More quotes
1 week
1 132.00
Extreme 1132
1 170.00
1 month
1 128.00
Extreme 1128
1 224.00
Current year
1 128.00
Extreme 1128
1 357.00
1 year
925.00
Extreme 925
1 357.00
3 years
880.00
Extreme 880
1 608.00
5 years
880.00
Extreme 880
2 065.00
10 years
76.88
Extreme 76.875
3 780.00
More quotes
Managers TitleAgeSince
Founder 70 81-02-05
Chief Administrative Officer 62 92-03-31
Chief Operating Officer 65 84-08-31
Members of the board TitleAgeSince
Founder 70 81-02-05
Chief Operating Officer 65 84-08-31
Director/Board Member 66 12-05-31
More insiders
Date Price Change Volume
24-04-26 1,161 +1.57% 700,800
24-04-25 1,143 -1.30% 108,900
24-04-24 1,158 +0.87% 178,500
24-04-23 1,148 -0.26% 90,900
24-04-22 1,151 +0.88% 150,500

Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am

More quotes
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1,161 JPY
Average target price
1,450 JPY
Spread / Average Target
+24.89%
Consensus